ES2066811T3 - Procedimiento para la fabricacion de ebselenio de alta pureza. - Google Patents

Procedimiento para la fabricacion de ebselenio de alta pureza.

Info

Publication number
ES2066811T3
ES2066811T3 ES89113827T ES89113827T ES2066811T3 ES 2066811 T3 ES2066811 T3 ES 2066811T3 ES 89113827 T ES89113827 T ES 89113827T ES 89113827 T ES89113827 T ES 89113827T ES 2066811 T3 ES2066811 T3 ES 2066811T3
Authority
ES
Spain
Prior art keywords
solution
acid
sodium
acids
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113827T
Other languages
English (en)
Inventor
Bernd-Rainer Dr Gunther
Rainer Dr Losch
Klaus Dr Steiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Application granted granted Critical
Publication of ES2066811T3 publication Critical patent/ES2066811T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12Selenazoles; Hydrogenated selenazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

EL INVENTO SE REFIERE A UN PROCEDIMIENTO DE (2-FENILO-1,2-BENZISOSELENOAZOL3(3H)-ONA DE FOMRULA (I). EL PROCEDIMIENTO CONSISTE: A) REDUCIR EL SELENO METALICO CON SULTOXILATO FORMALDEHIDO DE SODIO RONGALITA EN SOLUCIONES ACUOSALCALINAS DE SELENIURO SODICO ; B) TRANSFORMAR LOS SELENIUROS SODICOS OBTENIDOS CON ACIDOS ANTRANILICOS DIAZOTADO Y EN MEDIOS ALCALINOS PARA OBTENER LAS SALES SODICAS DE ACIDOS O DISELENOSDICILICO; C) TRATAR LOS ACIDOS O DISELENOSALICILICO CON TIONILCLORUROEN EXCESO PARA OBTENER CLORURO DE ACIDO DE O-CLOROSELENOBENZOICO Y D) TRANSFORMAR LOS CLORUROS DE ACIDO CLOROSELENOBENZOICO CON ANILINA EN SOLUCION ORGANICA. SE CARACTERIZA PORQUE: A) SE REALIZA A UNA TEMPERATURA ENTRE 20 Y 50 C DURANTE 0,5 A 2 HORAS; B) LA SOLUCION DE SELENIURO ALCALINA OBTENIDA SE TRANSFORMA CON ACIDO ANTRANILO ENTRE 0 Y 10 C DURANTE UNO A DOS HORAS; LA SOLUCION ALCALINA DE ACIDO O-DISELENOSALICILICO PRESENTE SE TAMPONA A PH ENTRE 7,5 Y 8,5 CON ACIDO ACETICO; LA SOLUCION OBTENIDA ENTURBIADA SE CLARIFICA; LA SOLICION CLARIFICADA SE TRATA CON CLORO ACTIVO; LA SOLUCION TRATADA CON CLORO ACTIVO SE LLEVA A UN PH ENTRE 5 Y 6 CON ACIDO ACETICO SEGUN LA SEPARACION DE CARBONO ACTIVO; LA SOLUCION SEPARADA Y PURIFICADA Y SECADA DE ACIDO O-DISELENOSALICILICO SE MEZCLA CON UN DISOLVENTE DEL GRUPO 1,2-DICLORUETANO O CLOROFORMO; LA SOLUCION SE CALIENTA EN UN SEPARADOR DE AGUA HASTA EBULLICION Y LA SOLUCION SE DESTILA AZETROPICAMENTE HASTA ELIMINAR TODA LA CANTIDAD DE AGUA.
ES89113827T 1988-08-10 1989-07-27 Procedimiento para la fabricacion de ebselenio de alta pureza. Expired - Lifetime ES2066811T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3827093A DE3827093A1 (de) 1988-08-10 1988-08-10 Verfahren zur herstellung von hochreinem ebselen

Publications (1)

Publication Number Publication Date
ES2066811T3 true ES2066811T3 (es) 1995-03-16

Family

ID=6360566

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113827T Expired - Lifetime ES2066811T3 (es) 1988-08-10 1989-07-27 Procedimiento para la fabricacion de ebselenio de alta pureza.

Country Status (12)

Country Link
US (1) US5008394A (es)
EP (1) EP0354412B1 (es)
JP (1) JPH0830064B2 (es)
AT (1) ATE117297T1 (es)
CA (1) CA1333175C (es)
DE (2) DE3827093A1 (es)
DK (1) DK173836B1 (es)
ES (1) ES2066811T3 (es)
FI (1) FI92694C (es)
IE (1) IE65777B1 (es)
NO (1) NO177142C (es)
PT (1) PT91414B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937169A1 (de) * 1989-11-08 1991-05-16 Nattermann A & Cie Benzylselenobenzamide von anilinen und benzylaminen
DK0729756T3 (da) * 1993-10-27 2000-06-05 Daiichi Seiyaku Co Granulært farmaceutisk præparat
DE4422237A1 (de) 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
CN1166651C (zh) * 2001-06-08 2004-09-15 北京大学药学院 具有抗炎和抗肿瘤作用r-双或糖苯丙异硒唑取代化合物
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
WO2010056710A1 (en) * 2008-11-11 2010-05-20 Biovista, Inc. Compositions and methods for treating eye diseases
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
US20200261417A1 (en) 2016-05-18 2020-08-20 Sound Pharmaceuticals Incorporated Treatment of meniere's disease
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113105379A (zh) * 2021-03-02 2021-07-13 暨南大学 一种以吊白块为还原剂制备硒代胱氨酸的方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3226286A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
FI893684A (fi) 1990-02-11
PT91414B (pt) 1995-05-04
IE892468L (en) 1990-02-10
NO893169L (no) 1990-02-12
EP0354412B1 (de) 1995-01-18
NO177142B (no) 1995-04-18
JPH0830064B2 (ja) 1996-03-27
ATE117297T1 (de) 1995-02-15
FI92694C (fi) 1994-12-27
US5008394A (en) 1991-04-16
CA1333175C (en) 1994-11-22
IE65777B1 (en) 1995-11-15
FI893684A0 (fi) 1989-08-03
EP0354412A2 (de) 1990-02-14
DE58908900D1 (de) 1995-03-02
NO893169D0 (no) 1989-08-04
DE3827093A1 (de) 1990-02-15
NO177142C (no) 1995-07-26
PT91414A (pt) 1990-03-08
DK173836B1 (da) 2001-12-10
DK390389D0 (da) 1989-08-09
DK390389A (da) 1990-02-11
EP0354412A3 (en) 1990-07-11
JPH02124880A (ja) 1990-05-14
FI92694B (fi) 1994-09-15

Similar Documents

Publication Publication Date Title
ES2066811T3 (es) Procedimiento para la fabricacion de ebselenio de alta pureza.
US2033909A (en) Manufacture of calcium levulinate
NO177963C (no) Fremgangsmåte for fremstilling av nye insulinderivater
ES466190A1 (es) Procedimiento para obtener albumina purificada.
ES2192630T3 (es) Procedimiento para aislar el acido 2-ceto-l-gulonico.
ATE31527T1 (de) P-oxibenzoesaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln mit hypolipaemischer wirkung.
FR2356423A1 (fr) Derives de l'acide thiazolidinecarboxylique, leur preparation et leur application comme medicaments
US4910222A (en) Cysteine derivatives having expectorant activity
HUT48195A (en) Process for producing carboxylic acid derivatives and pharmaceuticals comprising same
FR2457302A1 (fr) Nouveau procede de purification de l'acide ursodesoxycholique
Nelson et al. Synthesis of some esters of hippuric acid, and their hydrolysis by α-chymotrypsin
DE1768337C2 (de) 2-Phenylbenzo eckige Klammer auf b eckige Klammer zu -thiophen- und 2-Phenylnaphtho eckige Klammer auf 2,3b eckige Klammer zu -thiophen-3 (2H)on-1,1-dioxide und Verfahren zu ihrer Herstellung
US2361576A (en) Method of refining a crude 1-naphthylacetic acid
JPS6055491B2 (ja) β−ナフト−ルの精製方法
EP0344737A1 (en) Process for purifying alpha-substituted acetic acids
HARINGTON XXXIX. CHEMISTRY OF THYROXINE. I. ISOLATION OF THYROXINE FROM THE THYROID GLAND.
IT1254254B (it) Procedimento per la preparazione di acido iodesossicolico ad elevata purezza per impiego farmaceutico
IT1219459B (it) Procedimento per produrre forme cristalline di sali di litio, potassio e magnesio di citidindifosfocolina, forme cristalline cosi' ottenute e loro impiego farmaceutico
US3094471A (en) Process for the preparation of cis-p-hydroxycinnamic acid
ES8206482A1 (es) Procedimiento para la obtencion de amida de acido nicotinicopura a partir de amida de acido nicotinico bruta
GB384558A (en) Improvements in the purification and decolorisation of aromatic hydroxy-carboxylic ac
GB428815A (en) Process for the manufacture of laevo-ascorbic acid (vitamin-c)
SU1051097A1 (ru) Способ получени дихлорангидридов арилфосфоновых кислот
Morgan et al. 60. New derivatives of p-arsanilic acid. Part VI. p-Arsonopimelanilic and p-arsonosuberanilic acids and related compounds
SU101707A2 (ru) Способ получени роданида аммони

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354412

Country of ref document: ES